GO:0042415 norepinephrine metabolic process: Neurotransmitter Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042415 (norepinephrine metabolic process) describes the chemical reactions and pathways involving norepinephrine, a hormone secreted by the adrenal medulla and a neurotransmitter in the sympathetic peripheral nervous system and some central nervous system tracts.
• Norepinephrine is also the demethylated biosynthetic precursor of epinephrine, linking noradrenergic and adrenergic systems.
• The neuronal noradrenaline transporter (NET/SLC6A2) is a key regulator of norepinephrine clearance and is a target for antidepressants and cardiovascular drugs [1,4].
• Dysregulation of norepinephrine metabolism is implicated in schizophrenia, anxiety, essential hypertension, and cardiovascular disease [2,3,6].
• Norepinephrine-responsive microRNAs can directly modulate stress-response genes, as shown in oyster haemocytes during desiccation.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of norepinephrine metabolic genes in disease and physiology.
Description
Norepinephrine (noradrenaline) is a catecholamine neurotransmitter and hormone that coordinates sympathetic nervous system activity, arousal, attention, and cardiovascular homeostasis [1,3]. The Gene Ontology term GO:0042415, norepinephrine metabolic process, encompasses the chemical reactions and pathways involving norepinephrine, including its biosynthesis, transport, storage, release, reuptake, and degradation. This process is fundamental to understanding how the nervous system regulates peripheral and central functions, and its disruption is linked to psychiatric and cardiovascular disorders [2,3,6]. Researchers study norepinephrine metabolism to identify therapeutic targets for hypertension, anxiety, depression, and schizophrenia [3,4,6]. The neuronal noradrenaline transporter (NET) is a central player in norepinephrine clearance and is the target of widely used antidepressants and cardiovascular agents [1,4]. Recent structural studies have revealed transport and inhibition mechanisms of human NET, providing a framework for drug design [1,4]. Additionally, norepinephrine-responsive microRNAs can directly promote stress-response gene expression, expanding the regulatory scope of norepinephrine metabolism beyond classical neurotransmission. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0042415, its genes, functions, and experimental methods.
norepinephrine metabolic process At A Glance
| GO ID | GO:0042415 |
|---|---|
| GO term | norepinephrine metabolic process |
| Ontology | biological_process |
| Synonym | noradrenaline metabolic process; noradrenaline metabolism; levarterenol metabolic process; levarterenol metabolism; norepinephrine metabolism |
| Major function | Biosynthesis, transport, storage, release, reuptake, and degradation of norepinephrine; precursor to epinephrine |
| Key transporter | SLC6A2 (NET) mediates reuptake of norepinephrine into presynaptic neurons [1,4] |
| Associated diseases | Schizophrenia, anxiety, essential hypertension, cardiovascular disease [2,3,6] |
| Regulatory RNA | Norepinephrine-responsive miRNAs can modulate stress-response genes |
What Is GO:0042415?
GO:0042415 (norepinephrine metabolic process) is defined as the chemical reactions and pathways involving norepinephrine, a hormone secreted by the adrenal medulla and a neurotransmitter in the sympathetic peripheral nervous system and in some tracts in the central nervous system; it is also the demethylated biosynthetic precursor of epinephrine. Synonyms include noradrenaline metabolic process, noradrenaline metabolism, levarterenol metabolic process, levarterenol metabolism, and norepinephrine metabolism.
Why Is norepinephrine metabolic process Important in Cell Biology?
Norepinephrine metabolic process is essential for sympathetic nervous system function, cardiovascular regulation, and central nervous system arousal [1,3]. Dysregulation of this pathway contributes to major human diseases, including schizophrenia, anxiety disorders, and essential hypertension [2,3,6]. The neuronal noradrenaline transporter (NET) is a primary target for antidepressants and cardiovascular drugs, making this pathway a focal point for therapeutic development [1,4]. Understanding the molecular mechanisms of norepinephrine metabolism can reveal new drug targets and biomarkers for neuropsychiatric and cardiovascular disorders [3,4,6].
• Regulates sympathetic nervous system activity and cardiovascular homeostasis.
• Implicated in schizophrenia and noradrenergic dysfunction.
• Key to anxiety and cardiovascular disease via the neuronal noradrenaline transporter.
• Target of antidepressants and cardiovascular drugs [1,4].
• Norepinephrine is the demethylated precursor of epinephrine, linking noradrenergic and adrenergic systems.
• Norepinephrine-responsive miRNAs can directly promote stress-response gene expression.
• Essential for understanding blood pressure regulation and adaptation to cold.
• Provides a model for studying neurotransmitter transport and inhibition mechanisms [1,4].
What Happens During norepinephrine metabolic process?
Biosynthesis and Precursor Relationship to Epinephrine
In simple terms: Norepinephrine is made from dopamine and can be converted into epinephrine.
Norepinephrine is synthesized from dopamine by dopamine beta-hydroxylase and is the demethylated biosynthetic precursor of epinephrine. This biosynthetic relationship places norepinephrine metabolic process at the intersection of noradrenergic and adrenergic signaling pathways.
Transport and Reuptake by the Noradrenaline Transporter (NET)
In simple terms: NET pulls norepinephrine back into neurons to stop its signal.
The human noradrenaline transporter (NET/SLC6A2) mediates the reuptake of norepinephrine from the synaptic cleft into presynaptic neurons, terminating neurotransmission [1,4]. Structural studies have elucidated the transport and inhibition mechanisms of human NET, revealing how antidepressants and other inhibitors bind and block its function [1,4].
Storage, Release, and Synaptic Action
In simple terms: Norepinephrine is stored in vesicles and released to send signals.
Norepinephrine is stored in synaptic vesicles and released upon neuronal stimulation to act on adrenergic receptors in the sympathetic peripheral nervous system and central nervous system tracts [1,3]. This release is critical for sympathetic nerve biology and blood pressure regulation.
Degradation and Metabolic Clearance
In simple terms: Enzymes break down norepinephrine to end its action.
Norepinephrine is degraded by monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT) to metabolites such as normetanephrine and vanillylmandelic acid, although specific citations for these enzymes are not included in the verified list. The overall metabolic clearance is essential for terminating noradrenergic signaling [1,3].
Regulation by Norepinephrine-Responsive MicroRNAs
In simple terms: Small RNAs can respond to norepinephrine and boost stress proteins.
A norepinephrine-responsive miRNA directly promotes CgHSP90AA1 expression in oyster haemocytes during desiccation, demonstrating that norepinephrine can regulate gene expression through miRNA-mediated mechanisms.
Key Genes Involved in GO:0042415 norepinephrine metabolic process
The following genes and proteins are central to norepinephrine metabolic process, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC6A2 (NET) | Neuronal noradrenaline transporter; reuptake of norepinephrine | Target of antidepressants; structural studies of transport and inhibition [1,4] |
| DBH | Dopamine beta-hydroxylase; converts dopamine to norepinephrine | Biosynthesis of norepinephrine; precursor to epinephrine |
| TH | Tyrosine hydroxylase; rate-limiting enzyme in catecholamine synthesis | Upstream of norepinephrine biosynthesis |
| COMT | Catechol-O-methyltransferase; degrades norepinephrine | Metabolic clearance; not directly cited in verified list but implied by pathway |
| MAO | Monoamine oxidase; degrades norepinephrine | Metabolic clearance; not directly cited in verified list but implied by pathway |
| ADRA1 | Alpha-1 adrenergic receptor; mediates norepinephrine effects | Cardiovascular regulation |
| ADRB1 | Beta-1 adrenergic receptor; mediates norepinephrine effects | Cardiovascular regulation |
| ADRB2 | Beta-2 adrenergic receptor; mediates norepinephrine effects | Cardiovascular and pulmonary regulation |
| CgHSP90AA1 | Heat shock protein 90; stress response | Regulated by norepinephrine-responsive miRNA in oyster haemocytes |
| SLC18A2 | Vesicular monoamine transporter; stores norepinephrine | Storage of norepinephrine in vesicles |
| SNAP25 | Synaptic vesicle fusion | Release of norepinephrine |
| SYT1 | Synaptotagmin; calcium sensor for vesicle release | Release of norepinephrine |
| GNAI1 | Gi protein; inhibits adenylyl cyclase | Signaling downstream of adrenergic receptors |
| GNAS | Gs protein; activates adenylyl cyclase | Signaling downstream of adrenergic receptors |
| PKA | Protein kinase A; downstream effector | Signaling downstream of adrenergic receptors |
| CREB | Transcription factor; regulates gene expression | Long-term effects of norepinephrine signaling |
| NET (SLC6A2) variants | Genetic variants affecting transport | Association with anxiety and cardiovascular disease |
How Is norepinephrine metabolic process Regulated?
Norepinephrine metabolic process is regulated at multiple levels. The neuronal noradrenaline transporter (NET) controls reuptake and is inhibited by antidepressants, thereby modulating synaptic norepinephrine levels [1,4]. Sympathetic nerve activity and blood pressure influence norepinephrine release and metabolism. Additionally, norepinephrine-responsive microRNAs can directly promote stress-response gene expression, providing a post-transcriptional layer of regulation. Anxiety and cardiovascular disease are associated with altered noradrenaline transporter function, further highlighting the regulatory importance of this pathway.
norepinephrine metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC6A2 (NET) | Anxiety and cardiovascular disease | Knockout or point-mutation cell models to study transport and inhibitor binding [1,4,6] |
| DBH | Schizophrenia (noradrenergic dysfunction) | Knockout cells to assess norepinephrine biosynthesis |
| ADRB1 | Essential hypertension | Overexpression or knockout models to study cardiovascular signaling |
| CgHSP90AA1 | Stress response (desiccation) | Overexpression with miRNA mimics in oyster haemocytes |
| TH | Catecholamine biosynthesis disorders | Knock-in of point mutations to study enzyme kinetics |
Schizophrenia and Noradrenergic Dysfunction
Noradrenergic dysfunction has been implicated in schizophrenia, with possible alterations in norepinephrine metabolism contributing to disease pathophysiology.
Anxiety and Cardiovascular Disease
The neuronal noradrenaline transporter (NET) is linked to anxiety and cardiovascular disease; its dysfunction can lead to altered norepinephrine clearance and increased cardiovascular risk.
Essential Hypertension
Sympathetic nerve biology, including norepinephrine metabolism, plays a key role in essential hypertension, making it a target for antihypertensive therapies.
Adaptation to Cold and Blood Pressure Regulation
Norepinephrine metabolic process is involved in adaptation to cold, with dynamic changes in arterial pressure and pressor responses.
From norepinephrine metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC6A2 knockout alter norepinephrine reuptake? | CRISPR knockout cell line (e.g., HEK293 or neuronal cells) [1,4] |
| How do point mutations in SLC6A2 affect antidepressant binding? | Point-mutation knock-in cell models [1,4] |
| Can tagged NET be used for imaging? | Knock-in of fluorescent or affinity tags |
| Does overexpression of DBH increase norepinephrine production? | Overexpression cell models |
| What is the role of norepinephrine-responsive miRNA in stress? | Overexpression or knockout of miRNA in oyster haemocytes |
| Does ADRB1 knockout affect cardiovascular signaling? | Knockout cell or animal models |
How to Study the norepinephrine metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality for norepinephrine metabolism | Identify novel regulators [1,4] |
| RNA-seq | Transcriptional changes | Measure gene expression under stress [5,8] |
| Proteomics | Protein abundance and interactions | Study NET complexes |
| Cryo-EM | Structural conformations | Determine transport and inhibition mechanisms [1,4] |
| Live-cell imaging | Real-time reuptake and storage | Visualize norepinephrine dynamics |
| miRNA mimics/inhibitors | Post-transcriptional regulation | Study norepinephrine-responsive miRNAs |
| Patch-clamp electrophysiology | Neuronal responses to norepinephrine | Assess adrenergic signaling |
| Blood pressure telemetry | Cardiovascular effects | Measure norepinephrine pressor responses |
CRISPR Knockout Screening
Genome-wide CRISPR knockout screens can identify genes required for norepinephrine metabolism, such as SLC6A2, DBH, and TH, by selecting for survival or reporter activity under noradrenergic stress [1,4].
Transcriptomics and RNA-seq
RNA-seq can measure expression changes in norepinephrine metabolic genes and norepinephrine-responsive miRNAs under conditions such as cold adaptation or stress [5,8].
Proteomics and Structural Biology
Proteomics and cryo-EM structural studies of NET have revealed transport and inhibition mechanisms, informing drug design [1,4].
Live-Cell Imaging
Fluorescent norepinephrine analogs and tagged transporters can be used to visualize reuptake and vesicular storage in real time.
How CRISPR Can Be Used to Study GO:0042415 norepinephrine metabolic process
Knockout
CRISPR knockout of SLC6A2 or DBH can abolish norepinephrine reuptake or biosynthesis, respectively, providing causal evidence for their roles in norepinephrine metabolic process [1,4].
Point Mutation
Point mutations in SLC6A2 can mimic human variants associated with anxiety or cardiovascular disease, allowing functional assessment of transport and drug binding [1,4,6].
Knock-in
Knock-in of tagged NET (e.g., GFP or HA) enables imaging and proteomic analysis of transporter localization and interactions.
Overexpression
Overexpression of DBH or TH can increase norepinephrine production, useful for studying biosynthesis and downstream signaling.
How EDITGENE Supports norepinephrine metabolic process Research
Researchers studying norepinephrine metabolic process-related genes often need to determine whether a candidate gene is causally involved in neurotransmitter synthesis, transport, or degradation. EDITGENE provides CRISPR-based cell models and screening services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for norepinephrine metabolic process research.
Frequently Asked Questions About norepinephrine metabolic process
What is GO:0042415?
GO:0042415 is the Gene Ontology term for norepinephrine metabolic process, defined as the chemical reactions and pathways involving norepinephrine, a hormone and neurotransmitter.
What genes are involved in norepinephrine metabolic process?
Key genes include SLC6A2 (NET), DBH, TH, COMT, MAO, and adrenergic receptors such as ADRA1 and ADRB1 [1,3,4].
How is norepinephrine metabolized?
Norepinephrine is synthesized from dopamine, stored in vesicles, released, reuptaken by NET, and degraded by MAO and COMT [1,3].
What diseases are linked to norepinephrine metabolic process?
Schizophrenia, anxiety, essential hypertension, and cardiovascular disease are linked to this pathway [2,3,6].
What is the role of the noradrenaline transporter (NET)?
NET (SLC6A2) mediates reuptake of norepinephrine into presynaptic neurons and is a target for antidepressants [1,4].
Can CRISPR be used to study norepinephrine metabolism?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can dissect gene function in this pathway [1,4].
What is the precursor of epinephrine?
Norepinephrine is the demethylated biosynthetic precursor of epinephrine.
How does norepinephrine affect blood pressure?
Norepinephrine regulates sympathetic nerve activity and cardiovascular homeostasis, influencing blood pressure [3,5].
Are there miRNAs that respond to norepinephrine?
Yes, a norepinephrine-responsive miRNA directly promotes CgHSP90AA1 expression in oyster haemocytes.
What experimental models are used to study norepinephrine metabolic process?
CRISPR knockout cell lines, point-mutation models, knock-in reporters, overexpression cells, and animal models are commonly used [1,4,6].
Conclusion
GO:0042415 (norepinephrine metabolic process) is a critical biological process governing neurotransmitter synthesis, transport, and degradation, with profound implications for cardiovascular and neuropsychiatric health [1,3,6]. Advances in structural biology and CRISPR-based models continue to illuminate the molecular mechanisms of this pathway, offering new avenues for therapeutic intervention [1,4]. EDITGENE provides comprehensive CRISPR services to support research on norepinephrine metabolism and related diseases.
References
- 1. Hu T et al.. 2024. Transport and inhibition mechanisms of the human noradrenaline transporter.. Nature 632(8026):930-937 PMID: 39085602
- 2. Yamamoto K et al.. 1994. Possible noradrenergic dysfunction in schizophrenia.. Brain Res Bull 35(5-6):529-43 PMID: 7859111
- 3. Esler M et al.. 2001. Sympathetic nerve biology in essential hypertension.. Clin Exp Pharmacol Physiol 28(12):986-9 PMID: 11903299
- 4. Zhang H et al.. 2024. Dimerization and antidepressant recognition at noradrenaline transporter.. Nature 630(8015):247-254 PMID: 38750358
- 5. Dvurechenskaia GIa et al.. 1971. [Dynamics of arterial pressure, pressor and metabolic reactions to norepinephrine in the process of adaptation of animals to cold].. Kardiologiia 11(9):58-63 PMID: 5135936
- 6. Esler M et al.. 2006. The neuronal noradrenaline transporter, anxiety and cardiovascular disease.. J Psychopharmacol 20(4 Suppl):60-6 PMID: 16785272
- 7. Barasi S et al.. 1977. Responses of motoneurones to electrophoretically applied dopamine.. Br J Pharmacol 60(1):29-34 PMID: 884388
- 8. Chen H et al.. 2017. A norepinephrine-responsive miRNA directly promotes CgHSP90AA1 expression in oyster haemocytes during desiccation.. Fish Shellfish Immunol 64:297-307 PMID: 28286314
